Home
EVAX
EVAX News

Latest Evaxion Biotech A/S (EVAX) News on July 27, 2024

Evaxion Showcases Improved Performance of Key Building Block in AI-Immunology™ at Computational Biology Conference

GlobeNewswire

11 days ago

Evaxion Showcases Improved Performance of Key Building Block in AI-Immunology™ at Computational Biology Conference

Evaxion Reinforces Milestone Timeline and Provides Shareholder Update

GlobeNewswire

24 days ago

Evaxion Reinforces Milestone Timeline and Provides Shareholder Update

Evaxion Receives Positive Feedback on Patent Application for AI-Based Novel Cancer Vaccine Target Identification Method

GlobeNewswire

a month ago

Evaxion Receives Positive Feedback on Patent Application for AI-Based Novel Cancer Vaccine Target Identification Method

Evaxion Publishes Data, Showing 67% Objective Response Rate in Metastatic Melanoma for the AI-Designed Personalized Cancer Vaccine EVX-01, in Leading Medical Journal

GlobeNewswire

a month ago

Evaxion Publishes Data, Showing 67% Objective Response Rate in Metastatic Melanoma for the AI-Designed Personalized Cancer Vaccine EVX-01, in Leading Medical Journal

Here's Why Evaxion Biotecch (EVAX) Is a Great 'Buy the Bottom' Stock Now

Zacks

a month ago

Here's Why Evaxion Biotecch (EVAX) Is a Great 'Buy the Bottom' Stock Now

Lotto 6/49 - $64 million up for grabs in the next draw!

CNW Group

2 months ago

Lotto 6/49 - $64 million up for grabs in the next draw!

Returns On Capital At B&S Group (AMS:BSGR) Paint A Concerning Picture

Simply Wall St.

2 months ago

Returns On Capital At B&S Group (AMS:BSGR) Paint A Concerning Picture

Seoul says it will resume loudspeaker propaganda against North

AFP

2 months ago

Seoul says it will resume loudspeaker propaganda against North

It Might Not Be A Great Idea To Buy PATRIZIA SE (ETR:PAT) For Its Next Dividend

Simply Wall St.

2 months ago

It Might Not Be A Great Idea To Buy PATRIZIA SE (ETR:PAT) For Its Next Dividend

OUTsurance Group Insiders Placed Bullish Bets Worth R25.5m

Simply Wall St.

2 months ago

OUTsurance Group Insiders Placed Bullish Bets Worth R25.5m

Fed Meeting, Inflation Report, Apple’s WWDC, Broadcom Earnings, and More to Watch This Week

Barrons.com

2 months ago

Fed Meeting, Inflation Report, Apple’s WWDC, Broadcom Earnings, and More to Watch This Week

Just Three Days Till BREMER LAGERHAUS-GESELLSCHAFT -Aktiengesellschaft von 1877- (FRA:BLH) Will Be Trading Ex-Dividend

Simply Wall St.

2 months ago

Just Three Days Till BREMER LAGERHAUS-GESELLSCHAFT -Aktiengesellschaft von 1877- (FRA:BLH) Will Be Trading Ex-Dividend

An Intrinsic Calculation For ORIOR AG (VTX:ORON) Suggests It's 35% Undervalued

Simply Wall St.

2 months ago

An Intrinsic Calculation For ORIOR AG (VTX:ORON) Suggests It's 35% Undervalued

Evaxion Presents Positive and Validating Immune Data from Ongoing Phase 2 Trial with AI-Designed EVX-01 Vaccine at the ASCO Annual Meeting 2024

GlobeNewswire

2 months ago

Evaxion Presents Positive and Validating Immune Data from Ongoing Phase 2 Trial with AI-Designed EVX-01 Vaccine at the ASCO Annual Meeting 2024

Evaxion Announces Business Update and First Quarter 2024 Financial Results

GlobeNewswire

2 months ago

Evaxion Announces Business Update and First Quarter 2024 Financial Results

MT Newswires

2 months ago

Evaxion Biotech Plans to Unveil 'Positive' Data From Phase 2 Study of Advanced Melanoma Combination Treatment

Evaxion to Present New Positive Data from Ongoing Phase 2 Study on Lead Vaccine Candidate EVX-01 at the American Society of Clinical Oncology Annual Meeting 2024

GlobeNewswire

2 months ago

Evaxion to Present New Positive Data from Ongoing Phase 2 Study on Lead Vaccine Candidate EVX-01 at the American Society of Clinical Oncology Annual Meeting 2024

Evaxion Receives Nasdaq Notification

GlobeNewswire

3 months ago

Evaxion Receives Nasdaq Notification

Sidoti Events, LLC's Virtual May Micro-Cap Conference

ACCESSWIRE

3 months ago

Sidoti Events, LLC's Virtual May Micro-Cap Conference

Evaxion Announces Phase 2 Clinical Trial Update: First Patient Completed Dosing with Personalized Cancer Vaccine EVX-01

GlobeNewswire

3 months ago

Evaxion Announces Phase 2 Clinical Trial Update: First Patient Completed Dosing with Personalized Cancer Vaccine EVX-01

Evaxion (EVAX) Up on Upbeat Preclinical S. Aureus Vaccine Data

Zacks

4 months ago

Evaxion (EVAX) Up on Upbeat Preclinical S. Aureus Vaccine Data

Evaxion Biotech A/S (NASDAQ:EVAX) Q4 2023 Earnings Call Transcript

Insider Monkey

4 months ago

Evaxion Biotech A/S (NASDAQ:EVAX) Q4 2023 Earnings Call Transcript

Evaxion and Undisclosed Collaborator Announce Encouraging Results for EVX-B1 Vaccine Antigens Against Staphylococcus Aureus Infection

GlobeNewswire

4 months ago

Evaxion and Undisclosed Collaborator Announce Encouraging Results for EVX-B1 Vaccine Antigens Against Staphylococcus Aureus Infection

Evaxion Announces Business Update and Full Year 2023 Financial Results

GlobeNewswire

4 months ago

Evaxion Announces Business Update and Full Year 2023 Financial Results

When Will Evaxion Biotech A/S (NASDAQ:EVAX) Turn A Profit?

Simply Wall St.

4 months ago

When Will Evaxion Biotech A/S (NASDAQ:EVAX) Turn A Profit?

Evaxion Hosts R&D Day and Unveils the Broad Potential of Its AI-Immunology™ Platform

GlobeNewswire

4 months ago

Evaxion Hosts R&D Day and Unveils the Broad Potential of Its AI-Immunology™ Platform

Evaxion to Host R&D Day on March 19, 2024, Highlighting its Latest Technology Innovations

GlobeNewswire

5 months ago

Evaxion to Host R&D Day on March 19, 2024, Highlighting its Latest Technology Innovations

Evaxion Announces Successful Completion of the Initial Phases of Ongoing Vaccine Collaboration with MSD

GlobeNewswire

5 months ago

Evaxion Announces Successful Completion of the Initial Phases of Ongoing Vaccine Collaboration with MSD

Evaxion Regains Compliance with Nasdaq Minimum Bid Price Requirement

GlobeNewswire

6 months ago

Evaxion Regains Compliance with Nasdaq Minimum Bid Price Requirement

Evaxion Announces Closing of $15 Million Public Offering

GlobeNewswire

6 months ago

Evaxion Announces Closing of $15 Million Public Offering

Evaxion Biotech Announces Pricing of $15 Million Public Offering

GlobeNewswire

6 months ago

Evaxion Biotech Announces Pricing of $15 Million Public Offering

Evaxion to Develop Tailored Novel Cancer Vaccines Based upon a New Untapped Source of AI-Discovered Targets

GlobeNewswire

6 months ago

Evaxion to Develop Tailored Novel Cancer Vaccines Based upon a New Untapped Source of AI-Discovered Targets

Western New England Bancorp, Inc. Reports Results for Three Months and Year Ended December 31, 2023 and Declares Quarterly Cash Dividend

GlobeNewswire

6 months ago

Western New England Bancorp, Inc. Reports Results for Three Months and Year Ended December 31, 2023 and Declares Quarterly Cash Dividend

Outlook Therapeutics® Receives FDA Agreement Under Special Protocol Assessment (SPA) for 90 Day Non-Inferiority Study, NORSE EIGHT, and Announces Private Placement of Up to $172 Million to Advance ONS-5010

GlobeNewswire

6 months ago

Outlook Therapeutics® Receives FDA Agreement Under Special Protocol Assessment (SPA) for 90 Day Non-Inferiority Study, NORSE EIGHT, and Announces Private Placement of Up to $172 Million to Advance ONS-5010

Evaxion Announces Completion of ADS Ratio Change

GlobeNewswire

6 months ago

Evaxion Announces Completion of ADS Ratio Change

Business Wire

6 months ago

TransAct Announces BOHA! Solutions Order from Regional Assisted Living Communities

Zacks Small Cap Research

6 months ago

CTSO: CytoSorbents reports update on data results from important U.S. and Canadian STAR-T pivotal trial.

Groundbreaking Randomized Controlled Trial Reports Excellent Clinical Outcomes Using CytoSorb® Intraoperatively in Heart Transplant Patients

GlobeNewswire

6 months ago

Groundbreaking Randomized Controlled Trial Reports Excellent Clinical Outcomes Using CytoSorb® Intraoperatively in Heart Transplant Patients

Evaxion Announces Plan to Implement ADS Ratio Change

GlobeNewswire

7 months ago

Evaxion Announces Plan to Implement ADS Ratio Change

American Medical Association (AMA) Grants Cardio Diagnostics a Dedicated CPT PLA Reimbursement Code for Epi+Gen CHD, an AI-powered Test for Assessing the Probability of a Heart Attack or Coronary Heart Disease Event

Business Wire

7 months ago

American Medical Association (AMA) Grants Cardio Diagnostics a Dedicated CPT PLA Reimbursement Code for Epi+Gen CHD, an AI-powered Test for Assessing the Probability of a Heart Attack or Coronary Heart Disease Event

Forian Inc. (NASDAQ:FORA) insiders have recently purchased stock and their bets paid off last week as company hit US$112m market cap

Simply Wall St.

7 months ago

Forian Inc. (NASDAQ:FORA) insiders have recently purchased stock and their bets paid off last week as company hit US$112m market cap

CytoSorbents Provides Update on the STAR-T Trial and Reports Final Independent Data and Safety Monitoring Board Recommendation

GlobeNewswire

7 months ago

CytoSorbents Provides Update on the STAR-T Trial and Reports Final Independent Data and Safety Monitoring Board Recommendation

Yoshitsu Co., Ltd Reports First Six Months of Fiscal Year 2024 Financial Results

PR Newswire

7 months ago

Yoshitsu Co., Ltd Reports First Six Months of Fiscal Year 2024 Financial Results

Evaxion Biotech Announces Closing of Private Placement

GlobeNewswire

7 months ago

Evaxion Biotech Announces Closing of Private Placement

Evaxion Announces Business Update and Third Quarter 2023 Financial Results

GlobeNewswire

7 months ago

Evaxion Announces Business Update and Third Quarter 2023 Financial Results

Evaxion Biotech Announces Private Placement Financing

GlobeNewswire

7 months ago

Evaxion Biotech Announces Private Placement Financing

Insider Spends US$100k Buying More Shares In Cytosorbents

Simply Wall St.

7 months ago

Insider Spends US$100k Buying More Shares In Cytosorbents

Insider Buying: CEO Phillip Chan Acquires 75,188 Shares of CytoSorbents Corp (CTSO)

GuruFocus.com

7 months ago

Insider Buying: CEO Phillip Chan Acquires 75,188 Shares of CytoSorbents Corp (CTSO)

CytoSorbents Announces Closing of $10.3 Million Registered Direct Offering

GlobeNewswire

7 months ago

CytoSorbents Announces Closing of $10.3 Million Registered Direct Offering

Greenland Technologies to Present at Water Tower Research Investor Conference

PR Newswire

7 months ago

Greenland Technologies to Present at Water Tower Research Investor Conference

LightPath Announces Initial $4.7m Order from Lockheed Martin

ACCESSWIRE

8 months ago

LightPath Announces Initial $4.7m Order from Lockheed Martin

LightPath Technologies Schedules Annual Meeting of Stockholders

ACCESSWIRE

8 months ago

LightPath Technologies Schedules Annual Meeting of Stockholders

Zentek Reports Successful Testing of Aptamer Against Omicron Covid-19 Variant

ACCESSWIRE

8 months ago

Zentek Reports Successful Testing of Aptamer Against Omicron Covid-19 Variant

Evaxion to Unveil Potentially Groundbreaking AI-Immunology™ Precision Cancer Vaccine Concept

GlobeNewswire

8 months ago

Evaxion to Unveil Potentially Groundbreaking AI-Immunology™ Precision Cancer Vaccine Concept

Aligos Therapeutics To Present at the Piper Sandler Healthcare Conference

GlobeNewswire

8 months ago

Aligos Therapeutics To Present at the Piper Sandler Healthcare Conference

LightPath Technologies Postpones Annual Meeting of Stockholders

ACCESSWIRE

8 months ago

LightPath Technologies Postpones Annual Meeting of Stockholders

LightPath Technologies, Inc. (NASDAQ:LPTH) Q1 2024 Earnings Call Transcript

Insider Monkey

9 months ago

LightPath Technologies, Inc. (NASDAQ:LPTH) Q1 2024 Earnings Call Transcript

Share on Social Networks: